2. Academic Validation
  3. Irreversible protein kinase inhibitors: balancing the benefits and risks

Irreversible protein kinase inhibitors: balancing the benefits and risks

  • J Med Chem. 2012 Jul 26;55(14):6243-62. doi: 10.1021/jm3003203.
Tjeerd Barf 1,  Allard Kaptein
Affiliations

Affiliation

  • 1 Drug Discovery Unit, Covalution Pharma BV, Ravenstein, The Netherlands. tjeerd.barf@covalution.com
PMID: 22621397 DOI: 10.1021/jm3003203
Figures